
Voglivib 0.2mg Tablet
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglivib 0.2mg Tablet
Diabetic patients utilizing a controlled diet and other therapies may find relief with the 0.2mg Voglivib tablet for type 2 diabetes mellitus. This medication assists in postprandial blood glucose regulation. Administered immediately prior to meals, the precise dosage and frequency are determined by your physician for optimal glycemic control. Discontinuing Voglivib abruptly is inadvisable; doing so may elevate blood sugar, potentially resulting in serious complications such as renal impairment or vision loss. Successful management requires a comprehensive approach, incorporating a healthy diet, regular physical activity, and weight management as prescribed by your doctor. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include abdominal discomfort, decreased appetite, bowel irregularities (constipation or diarrhea), and flatulence. Report any persistent or bothersome side effects to your physician. While Voglivib itself does not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. In such instances, plain glucose is the appropriate countermeasure; table sugar is ineffective. Prior to initiating Voglivib, inform your physician about any pre-existing liver or kidney conditions, or bowel inflammation (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all medications currently in use is vital for patient safety. Excessive alcohol consumption should be avoided due to the elevated risk of hypoglycemia.
Primary Ingredients of Voglivib 0.2mg Tablet
There is no text provided to rephrase.
Uses of Voglivib 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Voglivib 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglivib 0.2mg Tablet on an empty stomach.
Common Side effects of Voglivib 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglivib 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglivib 0.2mg Tablet on an empty stomach.
How Voglivib 0.2mg Tablet works:
Voglivib 0.2mg tablets function as an antidiabetic agent by suppressing the activity of intestinal enzymes that digest complex carbohydrates into simple sugars like glucose. This action mitigates postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Voglivib 0.2mg tablets is strongly discouraged due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Voglivib 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglivib 0.2mg tablets safely. Available human data indicates minimal infant risk from this medication.
DrivingSAFE
Driving ability is typically unaffected by Voglivib 0.2mg tablets.
KidneyCAUTION
For individuals with severe kidney impairment, Voglivib 0.2mg tablets require careful administration. Dosage modification of Voglivib 0.2mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglivib 0.2mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Voglivib 0.2mg Tablet :
Omit any missed Voglivib 0.2mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Voglivib 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
